GSK selects Wave Life Sciences liver disease candidate for development, triggering $12M milestone payment

Wave Life Sciences said GSK selected a liver disease candidate for development, triggering a $12 million milestone payment to Wave. The selection advances the partnered programme into development.

Detected & updated continuously · Source: Nebula